Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Lukas biomedical Inc. (6814) Income Statement

Lukas biomedical Inc. Income Statement

Last quarter (Q2 2026), Lukas biomedical Inc.'s total revenue was NT$78.44M, a decrease of 19.49% from the same quarter last year. In Q2, Lukas biomedical Inc.'s net income was NT$-48.92M. See Lukas biomedical Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 179.49MNT$ 189.83MNT$ 231.83MNT$ 184.79MNT$ 157.62M
NT$ 95.69MNT$ 113.12MNT$ 133.89MNT$ 97.91MNT$ 96.06M
NT$ 176.85MNT$ 205.05MNT$ 177.45MNT$ 146.47MNT$ 140.31M
Depreciation and AmortizationNT$ 25.04MNT$ 28.55MNT$ 31.63MNT$ 36.07MNT$ 43.06M
NT$ -56.12MNT$ -62.88MNT$ -12.57MNT$ -10.93MNT$ -361.00K
NT$ -81.16MNT$ -92.14MNT$ -43.56MNT$ -48.47MNT$ -43.06M
NT$ -2.60MNT$ -2.34MNT$ -3.71MNT$ -1.45MNT$ -4.77M
NT$ -83.76MNT$ -94.47MNT$ -47.27MNT$ -49.92MNT$ -47.83M
NT$ -85.63MNT$ -94.38MNT$ -47.35MNT$ -50.07MNT$ -49.49M
Per Share Metrics
Basic EPSNT$ -2.04NT$ -2.38NT$ -1.28NT$ -1.35NT$ -1.50
Diluted EPSNT$ -2.04NT$ -2.38NT$ -1.28NT$ -1.35NT$ -1.50
Weighted Average Shares Outstanding41.87M39.58M36.87M37.01M33.08M
Weighted Average Shares Outstanding (Diluted)41.87M39.65M36.87M37.01M33.08M

Currency in TWD

Lukas biomedical Inc. Earnings and Revenue History

-150M0150M300M-60 %-40 %-20 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin